Cargando…

Seroprevalence of SARS-CoV-2 antibodies and knowledge, attitude and practice toward COVID-19 in the Republic of Srpska-Bosnia & Herzegovina: A population-based study

The aim of the study was to assess the seroprevalence of SARS-CoV-2 in the Republic of Srpska, Bosnia and Herzegovina, and to analyse the knowledge, attitudes and practices of the population toward COVID-19. This population-based study was conducted in a group of 1,855 randomly selected individuals...

Descripción completa

Detalles Bibliográficos
Autores principales: Mijović, Biljana, Mašić, Srdjan, Petković, Miroslav, Knežević, Darija, Aćimović, Jela, Djaković-Dević, Jelena, Puhalo-Sladoje, Dragana, Zeljković, Branislav, Spaić, Dragan, Bokonjić, Dejan, Škrbić, Ranko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797215/
https://www.ncbi.nlm.nih.gov/pubmed/35089944
http://dx.doi.org/10.1371/journal.pone.0262738
_version_ 1784641497218416640
author Mijović, Biljana
Mašić, Srdjan
Petković, Miroslav
Knežević, Darija
Aćimović, Jela
Djaković-Dević, Jelena
Puhalo-Sladoje, Dragana
Zeljković, Branislav
Spaić, Dragan
Bokonjić, Dejan
Škrbić, Ranko
author_facet Mijović, Biljana
Mašić, Srdjan
Petković, Miroslav
Knežević, Darija
Aćimović, Jela
Djaković-Dević, Jelena
Puhalo-Sladoje, Dragana
Zeljković, Branislav
Spaić, Dragan
Bokonjić, Dejan
Škrbić, Ranko
author_sort Mijović, Biljana
collection PubMed
description The aim of the study was to assess the seroprevalence of SARS-CoV-2 in the Republic of Srpska, Bosnia and Herzegovina, and to analyse the knowledge, attitudes and practices of the population toward COVID-19. This population-based study was conducted in a group of 1,855 randomly selected individuals from all municipalities from 1 December 2020 to 15 January 2021. All individuals were asked to sign a consent form and to fill in a questionnaire, following which a blood samples were collected. Total anti-SARS-CoV-2 antibodies were determined in serum specimens using the total Ab ELISA assay. The overall seroprevalence rate was 40.3%. Subjects aged <65 years were 2.06 times more likely to be seropositive than those aged ≥65, and 30% of seropositive individuals presented no COVID-19 symptoms. The household members of seropositive individuals were 2.24 times more likely to develop COVID-19 symptoms than the household members of seronegative individuals. More than 95% of respondents believe that preventive measures are very important to control the infection transmission. Majority of respondents wear the masks properly, maintain the required physical distance whenever possible and wash hands with soap. Nearly 50% of individuals were of the opinion that the vaccine could prevent the infection. This study showed that an overall SARS-CoV-2 seropositivity rate by the middle of January 2021 was very high. Attitudes and practices regarding the COVID-19 indicate that additional efforts should be taken in order to improve the health education with a focus on preventive measures and vaccination.
format Online
Article
Text
id pubmed-8797215
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-87972152022-01-29 Seroprevalence of SARS-CoV-2 antibodies and knowledge, attitude and practice toward COVID-19 in the Republic of Srpska-Bosnia & Herzegovina: A population-based study Mijović, Biljana Mašić, Srdjan Petković, Miroslav Knežević, Darija Aćimović, Jela Djaković-Dević, Jelena Puhalo-Sladoje, Dragana Zeljković, Branislav Spaić, Dragan Bokonjić, Dejan Škrbić, Ranko PLoS One Research Article The aim of the study was to assess the seroprevalence of SARS-CoV-2 in the Republic of Srpska, Bosnia and Herzegovina, and to analyse the knowledge, attitudes and practices of the population toward COVID-19. This population-based study was conducted in a group of 1,855 randomly selected individuals from all municipalities from 1 December 2020 to 15 January 2021. All individuals were asked to sign a consent form and to fill in a questionnaire, following which a blood samples were collected. Total anti-SARS-CoV-2 antibodies were determined in serum specimens using the total Ab ELISA assay. The overall seroprevalence rate was 40.3%. Subjects aged <65 years were 2.06 times more likely to be seropositive than those aged ≥65, and 30% of seropositive individuals presented no COVID-19 symptoms. The household members of seropositive individuals were 2.24 times more likely to develop COVID-19 symptoms than the household members of seronegative individuals. More than 95% of respondents believe that preventive measures are very important to control the infection transmission. Majority of respondents wear the masks properly, maintain the required physical distance whenever possible and wash hands with soap. Nearly 50% of individuals were of the opinion that the vaccine could prevent the infection. This study showed that an overall SARS-CoV-2 seropositivity rate by the middle of January 2021 was very high. Attitudes and practices regarding the COVID-19 indicate that additional efforts should be taken in order to improve the health education with a focus on preventive measures and vaccination. Public Library of Science 2022-01-28 /pmc/articles/PMC8797215/ /pubmed/35089944 http://dx.doi.org/10.1371/journal.pone.0262738 Text en © 2022 Mijović et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Mijović, Biljana
Mašić, Srdjan
Petković, Miroslav
Knežević, Darija
Aćimović, Jela
Djaković-Dević, Jelena
Puhalo-Sladoje, Dragana
Zeljković, Branislav
Spaić, Dragan
Bokonjić, Dejan
Škrbić, Ranko
Seroprevalence of SARS-CoV-2 antibodies and knowledge, attitude and practice toward COVID-19 in the Republic of Srpska-Bosnia & Herzegovina: A population-based study
title Seroprevalence of SARS-CoV-2 antibodies and knowledge, attitude and practice toward COVID-19 in the Republic of Srpska-Bosnia & Herzegovina: A population-based study
title_full Seroprevalence of SARS-CoV-2 antibodies and knowledge, attitude and practice toward COVID-19 in the Republic of Srpska-Bosnia & Herzegovina: A population-based study
title_fullStr Seroprevalence of SARS-CoV-2 antibodies and knowledge, attitude and practice toward COVID-19 in the Republic of Srpska-Bosnia & Herzegovina: A population-based study
title_full_unstemmed Seroprevalence of SARS-CoV-2 antibodies and knowledge, attitude and practice toward COVID-19 in the Republic of Srpska-Bosnia & Herzegovina: A population-based study
title_short Seroprevalence of SARS-CoV-2 antibodies and knowledge, attitude and practice toward COVID-19 in the Republic of Srpska-Bosnia & Herzegovina: A population-based study
title_sort seroprevalence of sars-cov-2 antibodies and knowledge, attitude and practice toward covid-19 in the republic of srpska-bosnia & herzegovina: a population-based study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797215/
https://www.ncbi.nlm.nih.gov/pubmed/35089944
http://dx.doi.org/10.1371/journal.pone.0262738
work_keys_str_mv AT mijovicbiljana seroprevalenceofsarscov2antibodiesandknowledgeattitudeandpracticetowardcovid19intherepublicofsrpskabosniaherzegovinaapopulationbasedstudy
AT masicsrdjan seroprevalenceofsarscov2antibodiesandknowledgeattitudeandpracticetowardcovid19intherepublicofsrpskabosniaherzegovinaapopulationbasedstudy
AT petkovicmiroslav seroprevalenceofsarscov2antibodiesandknowledgeattitudeandpracticetowardcovid19intherepublicofsrpskabosniaherzegovinaapopulationbasedstudy
AT knezevicdarija seroprevalenceofsarscov2antibodiesandknowledgeattitudeandpracticetowardcovid19intherepublicofsrpskabosniaherzegovinaapopulationbasedstudy
AT acimovicjela seroprevalenceofsarscov2antibodiesandknowledgeattitudeandpracticetowardcovid19intherepublicofsrpskabosniaherzegovinaapopulationbasedstudy
AT djakovicdevicjelena seroprevalenceofsarscov2antibodiesandknowledgeattitudeandpracticetowardcovid19intherepublicofsrpskabosniaherzegovinaapopulationbasedstudy
AT puhalosladojedragana seroprevalenceofsarscov2antibodiesandknowledgeattitudeandpracticetowardcovid19intherepublicofsrpskabosniaherzegovinaapopulationbasedstudy
AT zeljkovicbranislav seroprevalenceofsarscov2antibodiesandknowledgeattitudeandpracticetowardcovid19intherepublicofsrpskabosniaherzegovinaapopulationbasedstudy
AT spaicdragan seroprevalenceofsarscov2antibodiesandknowledgeattitudeandpracticetowardcovid19intherepublicofsrpskabosniaherzegovinaapopulationbasedstudy
AT bokonjicdejan seroprevalenceofsarscov2antibodiesandknowledgeattitudeandpracticetowardcovid19intherepublicofsrpskabosniaherzegovinaapopulationbasedstudy
AT skrbicranko seroprevalenceofsarscov2antibodiesandknowledgeattitudeandpracticetowardcovid19intherepublicofsrpskabosniaherzegovinaapopulationbasedstudy